Amblyopia

Digital Therapeutic Luminopia One is approved in the US for Improve Vision in Children with Amblyopia

USA，CAMBRIDGE, Mass October 20, 2021 Luminopia, a digital therapeutics company, today announced that the U.S. Food and Drug Administration (FDA) has granted de novo premarket approval for Luminopia One as a prescription therapy to improve vision in children with amblyopia (lazy eye), the leading cause of vision loss in children.…